Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

GLP toxicology and Pharmacokinetic/Pharmacodynamics studies

  • First published: 19 December 2017
  • Last modified: 19 December 2017
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
Published by:
Porton Biopharma Limited
Authority ID:
AA39833
Publication date:
19 December 2017
Deadline date:
19 January 2018
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Porton Biopharma Limited (PBL) has a requirement for a Contract Research Organisation (CRO) to perform GLP toxicology and pharmacokinetic/pharmacodynamics studies, including relevant assay development and validation. Full details will be provided upon implementation of a confidentiality agreement.

Full notice text

Prior information notice

This notice is a call for competition

Section I: Contracting authority

I.1) Name and addresses

Porton Biopharma Ltd

Manor Farm Road, Porton Down

Salisbury

SP2 0QT

UK

E-mail: Jeff.Pike@phe.gov.uk

NUTS: UKK

Internet address(es)

Main address: https://phe.bravosolution.co.uk

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.3) Communication

Access to the procurement documents is restricted. Further information can be obtained at:

https://phe.bravosolution.co.uk


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://phe.bravosolution.co.uk


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Other: Research

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

GLP toxicology and Pharmacokinetic/Pharmacodynamics studies

II.1.2) Main CPV code

73110000

 

II.1.3) Type of contract

Services

II.1.4) Short description

Porton Biopharma Limited (PBL) has a requirement for a Contract Research Organisation (CRO) to perform GLP toxicology and pharmacokinetic/pharmacodynamics studies, including relevant assay development and validation. Full details will be provided upon implementation of a confidentiality agreement.

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

33000000

II.2.3) Place of performance

NUTS code:

UKK

II.2.4) Description of the procurement

Porton Biopharma Limited (PBL) has a requirement for a Contract Research Organisation (CRO) to perform GLP toxicology and pharmacokinetic/pharmacodynamics studies, including relevant assay development and validation. Full details will be provided upon implementation of a confidentiality agreement.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Restricted procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of expressions of interest

Date: 19/01/2018

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

Porton Biopharma Ltd

Salisbury

UK

VI.5) Date of dispatch of this notice

14/12/2017

Coding

Commodity categories

ID Title Parent category
33000000 Medical equipments, pharmaceuticals and personal care products Materials and Products
73110000 Research services Research and experimental development services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
Jeff.Pike@phe.gov.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.